Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06323226

The Impact of Sepsis on Long-term Outcomes in Critical Ill Children With Sepsis

This study is conducted in critically ill children with sepsis with a five years follow-up. We aim to investigate the impact of sepsis on long-term outcomes including growth, neurodevelopment, survival rate, quality of life.

Recruiting

Interested in participating?

Request Info

Key information

Age range

0 year–16 year

Sex eligibility

All sexes

Study type

Observational

Primary location

West China Hospital of Sichuan University

Chengdu, Sichuan, China

Location status: Recruiting

Location contact

Ji Yi, Doctor

CONTACT

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

We included critically ill children with sepsis who successfully discharged from pediatric Intensive care units, age < 16 years.

We also included age, sex, illness severity matched critically ill children as control group.

Exclusion criteria

We excluded children with underlying diseases, cancer, hematologic malignancy.

Treatment and study plan

Primary outcomes

  1. Mortality

    Time frame: Five years

    Rate of death in 5-years follow-up

Study contacts

Contact information is provided by the study sponsor or research team.

Yi Ji, PhD, MD

CONTACT

[email protected]

8618980606865

Sponsors and collaborators

Lead sponsor

West China Hospital

Other

Registry information

Important dates

Study start
2019
Primary completion
2027
Study completion
2027
First posted
Mar 21, 2024
Registry last updated
Jan 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.